COMMUNIQUÉS West-GlobeNewswire

Kairos Pharma Closing of $6.2 Million Initial Public Offering
17/09/2024
LOS ANGELES, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company”) (NYSE American: KAPA), a clinical stage biopharmaceutical company developing cancer therapeutics designed to reverse [...]
Independent Directors of 23andMe Resign from Board
17/09/2024
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- The independent directors of the Board of 23andMe Holding Co. (Nasdaq: ME), today sent the following letter to Anne Wojcicki, Chief Executive Officer, Co- [...]
Traws Pharma, Inc. Announces Special Shareholders Meeting Results
17/09/2024
Three proposals, including a reverse stock split, were submitted and approved Traws Board subsequently approved a 1-for-25 reverse stock split Traws’ shares expected to begin trading on a split-adjusted basis on [...]
Jushi Holdings Inc. Announces Options Issued to Executive Officers
17/09/2024
BOCA RATON, Fla., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, is pleased to announce that [...]
RadNet, Inc. to Present at the Sidoti & Company Small Cap 2024 Virtual Conference on Wednesday, September 18th
17/09/2024
LOS ANGELES, Sept. 17, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
Structure Therapeutics Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer
17/09/2024
SAN FRANCISCO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and [...]
Fairway Consulting Group Appoints Brennan Clark as Vice President of Executive Search
17/09/2024
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Fairway Consulting Group (FCG) , a leading executive search firm focused on providing outstanding talent solutions for the pharmaceutical, biotechnology, diagnostic, and [...]
Move Health Holdings Corp. and No Fear Counselling Corp. Complete Merger Transaction
17/09/2024
VANCOUVER, British Columbia and TORONTO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Move Health Holdings Corp . (“Move Health”) and No Fear Counselling Corp . (“No Fear Counselling”), two of Canada’s foremost health and [...]
Inteleos Donates 49 Laptops to Annapolis Trust, Empowering Disadvantaged Students with Technology Skills
17/09/2024
ROCKVILLE, Md., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Inteleos, a global nonprofit healthcare certification organization, is proud to announce the donation of 49 laptops to the Annapolis Trust , a nonprofit organization [...]
FDA approves Novartis Kisqali® to reduce risk of recurrence in people with HR+/HER2- early breast cancer
17/09/2024
Ad hoc announcement pursuant to Art. 53 LR Broad indication in HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence approximately doubles population eligible for CDK4/6 inhibitor adjuvant [...]
EssilorLuxottica unveils plans for its new corporate headquarters in Paris
17/09/2024
EssilorLuxottica unveils plans for its new corporate headquarters in Paris Paris, France (September 17, 2024) – EssilorLuxottica announced today the signing of a long-term pre-letting agreement for its new global [...]
EssilorLuxottica dévoile son futur siège social à Paris
17/09/2024
EssilorLuxottica dévoile son futur siège social à Paris Paris, France (17septembre 2024) – EssilorLuxottica annonce la signature d'un bail de long-terme pour l’installation de son nouveau siège mondial à Paris, à [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
17/09/2024
Déclaration de transactions sur actions propres Paris, France (17 septembre 2024, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 10 septembre [...]
Idorsia continues to further the science of sleep and insomnia with new daridorexant data and analyses published at Sleep Europe 2024
17/09/2024
Allschwil, Switzerland – September 17, 2024 Idorsia Ltd (SIX: IDIA) today announced that new data and analyses of daridorexant, Idorsia’s dual orexin receptor antagonist for the treatment of adults with chronic insomnia [...]
Stryker completes acquisition of care.ai
17/09/2024
Portage, Michigan, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), announced that it has completed the previously announced acquisition of care.ai, a privately held company specializing in delivering AI-assisted [...]
Crossject to report first-half 2024 financial results and host webcast on September 23, 2024
17/09/2024
Dijon, France, 17 September, 2024 - Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing medicines for emergency situations harnessing its award-winning needle-free auto-injector ZENEO [...]
Crossject publiera ses résultats financiers du premier semestre et organisera un webcast le 23 Septembre 2024
17/09/2024
Dijon, France, 17 septembre 2024 - Crossject (ISIN : FR0011716265 ; Euronext : ALCJ), société pharmaceutique spécialisée dans le développement de médicaments pour les situations d'urgence exploitant son auto-injecteur [...]
Impact BioMedical Inc. Announces the Closing of its Initial Public Offering
17/09/2024
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced the closing of its [...]
Le seul vaccin contre le choléra à dose unique au Canada est disponible dans tout le pays
17/09/2024
TORONTO, 17 sept. 2024 (GLOBE NEWSWIRE) -- Bavarian Nordic, l’un des principaux fournisseurs mondiaux de vaccins pour voyageurs, a annoncé aujourd’hui la disponibilité commerciale de VAXCHORA ® , le seul vaccin oral à [...]

Pages